Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters

Indazole carboxamide synthetic cannabinoid, AB-PINACA, has been placed into Schedule I of the Controlled Substances Act by the US Drug Enforcement Administration since 2015. Despite the possibility of AB-PINACA exposure in drug abusers, the interactions between AB-PINACA and drug-metabolizing enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Eun Jeong, Park, Ria, Jeon, Ji-Hyeon, Cho, Yong-Yeon, Lee, Joo Young, Kang, Han Chang, Song, Im-Sook, Lee, Hye Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692329/
https://www.ncbi.nlm.nih.gov/pubmed/33138123
http://dx.doi.org/10.3390/pharmaceutics12111036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692329/
https://www.ncbi.nlm.nih.gov/pubmed/33138123
http://dx.doi.org/10.3390/pharmaceutics12111036

Ejemplares similares